| Product Code: ETC6190849 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Australian sexually transmitted infections (STI) market encompasses diagnostic testing, prevention methods, and treatment solutions for various infections. With rising cases of STIs like chlamydia, syphilis, and HIV, there is an increasing focus on education, prevention campaigns, and innovative treatments. Government-funded programs, alongside advances in medical technology and public health awareness, significantly influence the growth of this market.
The Australia sexually transmitted infections (STIs) market is experiencing growth, driven by a combination of increased public awareness, regular screenings, and an expanding pool of treatments. With a focus on prevention, diagnostic services, and treatment options, the market is showing signs of expansion due to the rise in the number of cases of common STIs like chlamydia, gonorrhea, and syphilis. Government programs, such as subsidized testing and counseling, have been pivotal in encouraging safe sexual practices, driving up testing rates. Additionally, the availability of at-home testing kits and rapid diagnostic tools has enhanced early detection, thus boosting the overall market.
One of the key challenges in Australias sexually transmitted infections (STIs) market is the social stigma associated with STIs, which discourages many individuals from seeking timely diagnosis and treatment. Public awareness campaigns are often insufficient in addressing misconceptions and promoting preventive measures. Additionally, disparities in healthcare access among Indigenous populations and in remote regions exacerbate the issue. The emergence of new pathogens and changing sexual behavior patterns also require constant updates in surveillance and healthcare strategies.
The STI market intersects diagnostics, therapeutics, and awareness sectors. Key areas for investment include digital STI tracking and notification platforms, prevention campaigns, youth-targeted education programs, and public-private partnerships to improve testing and treatment access.
The STI market is shaped by national sexual health policies focusing on prevention, diagnosis, and treatment. Government-supported initiatives promote free or subsidized STI testing and treatment, especially through public clinics and outreach programs. Regulatory oversight by the TGA ensures that pharmaceuticals, diagnostics, and prevention tools meet quality standards.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Sexually Transmitted Infections Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Sexually Transmitted Infections Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Sexually Transmitted Infections Market - Industry Life Cycle |
3.4 Australia Sexually Transmitted Infections Market - Porter's Five Forces |
3.5 Australia Sexually Transmitted Infections Market Revenues & Volume Share, By Location of Testing, 2021 & 2031F |
3.6 Australia Sexually Transmitted Infections Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Australia Sexually Transmitted Infections Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 Australia Sexually Transmitted Infections Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Australia Sexually Transmitted Infections Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Australia Sexually Transmitted Infections Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and education about sexual health in Australia |
4.2.2 High prevalence of risky sexual behaviors among certain demographics |
4.2.3 Technological advancements in diagnostic tools and treatment options |
4.3 Market Restraints |
4.3.1 Stigma associated with sexually transmitted infections (STIs) |
4.3.2 Limited access to healthcare services and testing facilities in remote areas |
4.3.3 Budget constraints affecting government funding for STI prevention programs |
5 Australia Sexually Transmitted Infections Market Trends |
6 Australia Sexually Transmitted Infections Market, By Types |
6.1 Australia Sexually Transmitted Infections Market, By Location of Testing |
6.1.1 Overview and Analysis |
6.1.2 Australia Sexually Transmitted Infections Market Revenues & Volume, By Location of Testing, 2021- 2031F |
6.1.3 Australia Sexually Transmitted Infections Market Revenues & Volume, By Laboratory Testing, 2021- 2031F |
6.1.4 Australia Sexually Transmitted Infections Market Revenues & Volume, By PCR, 2021- 2031F |
6.1.5 Australia Sexually Transmitted Infections Market Revenues & Volume, By Immunochromatographic assays, 2021- 2031F |
6.1.6 Australia Sexually Transmitted Infections Market Revenues & Volume, By Flow Cytometers, 2021- 2031F |
6.1.7 Australia Sexually Transmitted Infections Market Revenues & Volume, By Differential Light Scattering machines, 2021- 2031F |
6.1.8 Australia Sexually Transmitted Infections Market Revenues & Volume, By Enzyme Linked Immunosorbent Assay (ELISA), 2021- 2031F |
6.2 Australia Sexually Transmitted Infections Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Australia Sexually Transmitted Infections Market Revenues & Volume, By HIV/AIDS, 2021- 2031F |
6.2.3 Australia Sexually Transmitted Infections Market Revenues & Volume, By Human Papilloma Virus (HPV), 2021- 2031F |
6.2.4 Australia Sexually Transmitted Infections Market Revenues & Volume, By Gonorrhea, 2021- 2031F |
6.2.5 Australia Sexually Transmitted Infections Market Revenues & Volume, By Syphilis, 2021- 2031F |
6.2.6 Australia Sexually Transmitted Infections Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Australia Sexually Transmitted Infections Market, By Treatment |
6.3.1 Overview and Analysis |
6.3.2 Australia Sexually Transmitted Infections Market Revenues & Volume, By Antibiotics, 2021- 2031F |
6.3.3 Australia Sexually Transmitted Infections Market Revenues & Volume, By Antiviral, 2021- 2031F |
6.4 Australia Sexually Transmitted Infections Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Australia Sexually Transmitted Infections Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Australia Sexually Transmitted Infections Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4.4 Australia Sexually Transmitted Infections Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Australia Sexually Transmitted Infections Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Australia Sexually Transmitted Infections Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Australia Sexually Transmitted Infections Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 Australia Sexually Transmitted Infections Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.5 Australia Sexually Transmitted Infections Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Sexually Transmitted Infections Market Import-Export Trade Statistics |
7.1 Australia Sexually Transmitted Infections Market Export to Major Countries |
7.2 Australia Sexually Transmitted Infections Market Imports from Major Countries |
8 Australia Sexually Transmitted Infections Market Key Performance Indicators |
8.1 Percentage increase in the number of individuals seeking STI testing annually |
8.2 Rate of adoption of new STI treatment guidelines by healthcare providers |
8.3 Number of public health campaigns promoting STI prevention and testing |
8.4 Percentage of at-risk populations reached by STI education programs |
9 Australia Sexually Transmitted Infections Market - Opportunity Assessment |
9.1 Australia Sexually Transmitted Infections Market Opportunity Assessment, By Location of Testing, 2021 & 2031F |
9.2 Australia Sexually Transmitted Infections Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Australia Sexually Transmitted Infections Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.4 Australia Sexually Transmitted Infections Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Australia Sexually Transmitted Infections Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Australia Sexually Transmitted Infections Market - Competitive Landscape |
10.1 Australia Sexually Transmitted Infections Market Revenue Share, By Companies, 2024 |
10.2 Australia Sexually Transmitted Infections Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here